title: Deficient iNOS in inflammatory bowel disease intestinal microvascular endothelial cells results in increased leukocyte adhesion.
abstract: Microvascular endothelial cells play a key role in inflammation by undergoing activation and recruiting circulating immune cells into tissues and foci of inflammation, an early and rate-limiting step in the inflammatory process. We have previously [Binion et al., Gastroenterology112:1898-1907, 1997] shown that human intestinal microvascular endothelial cells (HIMEC) isolated from surgically resected inflammatory bowel disease (IBD) patient tissue demonstrate significantly increased leukocyte binding in vitro compared to normal HIMEC. Our studies [Binion et al., Am. J. Physiol.275 (Gastrointest. Liver Physiol. 38):G592-G603, 1998] have also demonstrated that nitric oxide (NO) production by inducible nitric oxide synthase (iNOS) normally plays a key role in downregulating HIMEC activation and leukocyte adhesion. Using primary cultures of HIMEC derived from normal and IBD patient tissues, we sought to determine whether alterations in iNOS-derived NO production underlies leukocyte hyperadhesion in IBD. Both nonselective (N(G)-monomethyl-L-arginine) and specific (N-Iminoethyl-L-lysine) inhibitors of iNOS significantly increased leukocyte binding by normal HIMEC activated with cytokines and lipopolysaccharide (LPS), but had no effect on leukocyte adhesion by similarly activated IBD HIMEC. When compared to normal HIMEC, IBD endothelial cells had significantly decreased levels of iNOS mRNA, protein, and NO production following activation. Addition of exogenous NO by co-culture with normal HIMEC or by pharmacologic delivery with the long-acting NO donor detaNONOate restored a normal leukocyte binding pattern in the IBD HIMEC. These data suggest that loss of iNOS expression is a feature of chronically inflamed microvascular endothelial cells, which leads to enhanced leukocyte binding, potentially contributing to chronic, destructive inflammation in IBD.
authors.affiliation: Division of Gastroenterology and Hepatology, Digestive Disease Center, and Cardiovascular Research Center, Froedtert Memorial Lutheran Hospital and The Medical College of Wisconsin, Milwaukee, WI 53226, USA. dbinion@mcw.edu
authors.forename: D G
authors.initials: DG
authors.lastname: Binion
authors.forename: P
authors.initials: P
authors.lastname: Rafiee
authors.forename: K S
authors.initials: KS
authors.lastname: Ramanujam
authors.forename: S
authors.initials: S
authors.lastname: Fu
authors.forename: P J
authors.initials: PJ
authors.lastname: Fisher
authors.forename: M T
authors.initials: MT
authors.lastname: Rivera
authors.forename: C P
authors.initials: CP
authors.lastname: Johnson
authors.forename: M F
authors.initials: MF
authors.lastname: Otterson
authors.forename: G L
authors.initials: GL
authors.lastname: Telford
authors.forename: K T
authors.initials: KT
authors.lastname: Wilson
mesh_terms: D002448:Cell Adhesion / Q000502:physiology; D002478:Cells, Cultured; D004730:Endothelium, Vascular / Q000201:enzymology* / Q000473:pathology*; D005609:Free Radicals / Q000378:metabolism; D006801:Humans; D015212:Inflammatory Bowel Diseases / Q000201:enzymology* / Q000235:genetics / Q000473:pathology*; D007422:Intestines / Q000098:blood supply*; D007962:Leukocytes / Q000473:pathology*; D009569:Nitric Oxide / Q000096:biosynthesis; D019001:Nitric Oxide Synthase / Q000172:deficiency* / Q000235:genetics; D052247:Nitric Oxide Synthase Type II; D012333:RNA, Messenger / Q000235:genetics / Q000378:metabolism
chemical_list: D005609:Free Radicals; D012333:RNA, Messenger; D009569:Nitric Oxide; C496319:NOS2 protein, human; D019001:Nitric Oxide Synthase; D052247:Nitric Oxide Synthase Type II